Douglas Crombie Anderson

Douglas Crombie Anderson

Corporate Officer/Principal presso The Association for Research in Vision & Ophthalmology

72 anni
Commercial Services
Health Technology
Consumer Services

Provenienza dei contatti di primo grado di Douglas Crombie Anderson

EntitàTipo di entitàSettore Industriale
28
Non-Profit Organization Miscellaneous Commercial Services 28

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Douglas Crombie Anderson tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
Miscellaneous Commercial Services

Jay L. Federman

Adrienne Graves

Stephen R. Fransen

Ryo Kubota

Joan W. Miller

Martin B. Wax

Peter Hnik

Michael Belkin

Peter John McDonnell

Thomas Ciulla

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Macula Society

Jay L. Federman

Jordi Monés Carilla

Thomas Ciulla

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The Retina Society

Jay L. Federman

Jordi Monés Carilla

Thomas Ciulla

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

American Society of Retinal Specialists

Jay L. Federman

Jordi Monés Carilla

Thomas Ciulla

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The American Society of Cataract & Refractive Surgery

Adrienne Graves

George W. Rozakis

Timothy R. Willis

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Adrienne Graves

Martin B. Wax

Glenn Noronha

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Investment Trusts/Mutual Funds

Adrienne Graves

Martin B. Wax

Michael Belkin

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

VISIONEERING TECHNOLOGIES, INC. Electronic Components

Peg Achenbach

Kuang-mon Tuan

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Hospital/Nursing Management

Uri Polat

Michael Belkin

Corporate Officer/Principal

Corporate Officer/Principal

PHIO PHARMACEUTICALS CORP. Biotechnology

Pamela A. Pavco

Lyn Libertine

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

IVERIC BIO, INC. Pharmaceuticals: Generic

Adrienne Graves

Thomas Ciulla

Chairman

Corporate Officer/Principal

College/University

Martin B. Wax

Peter John McDonnell

Doctorate Degree

Corporate Officer/Principal

British Contact Lens Association

Peg Achenbach

Kuang-mon Tuan

Corporate Officer/Principal

Corporate Officer/Principal

American Academy of Ophthalmology Foundation

Adrienne Graves

Jordi Monés Carilla

Director/Board Member

Corporate Officer/Principal

CLEARSIDE BIOMEDICAL, INC. Pharmaceuticals: Major

Glenn Noronha

Thomas Ciulla

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Harvard Medical School College/University

Joan W. Miller

Dimitri Azar

Corporate Officer/Principal

Corporate Officer/Principal

Tear Film & Ocular Surface Society

Dimitri Azar

Christopher Murphy

Director/Board Member

Corporate Officer/Principal

Medical/Nursing Services

Joan W. Miller

Dimitri Azar

Director/Board Member

Corporate Officer/Principal

Medical/Nursing Services

Jay L. Federman

Stephen R. Fransen

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Jay L. Federman

Dimitri Azar

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

George W. Rozakis

Lyn Libertine

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Joanne Angle

Director/Board Member

University of Cambridge College/University

Michael Belkin

Graduate Degree

Miscellaneous Commercial Services

Michael Belkin

Corporate Officer/Principal

Medical/Nursing Services

Michael Belkin

Founder

AERIE PHARMACEUTICALS, INC. Pharmaceuticals: Major

Peter John McDonnell

Director/Board Member

Israel Defense Forces Sovereign

Michael Belkin

Corporate Officer/Principal

Israeli Soociety For Eye & Vision Research

Michael Belkin

Founder

Electronic Components

Michael Belkin

Director/Board Member

Biotechnology

Michael Belkin

Founder

ALLERGAN, INC. Pharmaceuticals: Major

Peter John McDonnell

Director/Board Member

Alliance for Eye & Vision Research

Peter John McDonnell

President

Medical/Nursing Services

Peter John McDonnell

Director/Board Member

Wilmer Eye Institute

Peter John McDonnell

Director/Board Member

Pan-American Association of Ophthalmology

Peter John McDonnell

Corporate Officer/Principal

University of California, Irvine College/University

Peter John McDonnell

Corporate Officer/Principal

ALLERGAN PLC Pharmaceuticals: Major

Peter John McDonnell

Director/Board Member

American University College/University

Peter John McDonnell

Corporate Officer/Principal

Maryland Society of Eye Physicians & Surgeons

Peter John McDonnell

Corporate Officer/Principal

The Johns Hopkins University School of Medicine College/University

Peter John McDonnell

Doctorate Degree

National Alliance for Eye & Vision Research

Peter John McDonnell

President

Miscellaneous Commercial Services

Peter John McDonnell

Director/Board Member

ESCALON MEDICAL CORP. Medical Specialties

Jay L. Federman

Director/Board Member

University of British Columbia College/University

Peter Hnik

Graduate Degree

College/University

Michael Belkin

Corporate Officer/Principal

International Brain Research Organization

Uri Polat

Corporate Officer/Principal

Statistiche

Distribuzione geografica

Stati Uniti 38
Israele 9
Regno Unito 3
Irlanda 2
Canada 2

Settori

Health Technology 14
Consumer Services 9
Commercial Services 7
Health Services 6
Electronic Technology 3

Posizioni

Corporate Officer/Principal 159
Director/Board Member 88
Chief Tech/Sci/R&D Officer 29
Doctorate Degree 23
Independent Dir/Board Member 22
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA